These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 12483541

  • 1. Microcirculation as a target for the anti-inflammatory properties of statins.
    Scalia R, Stalker TJ.
    Microcirculation; 2002 Dec; 9(6):431-42. PubMed ID: 12483541
    [Abstract] [Full Text] [Related]

  • 2. Statins and endothelial dysfunction.
    Larose E, Ganz P.
    Semin Vasc Med; 2004 Nov; 4(4):333-46. PubMed ID: 15861315
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Statins and their role in vascular protection.
    Mason JC.
    Clin Sci (Lond); 2003 Sep; 105(3):251-66. PubMed ID: 12793855
    [Abstract] [Full Text] [Related]

  • 6. Immunomodulation by statins: inhibition of cholesterol vs. isoprenoid biosynthesis.
    Kuipers HF, van den Elsen PJ.
    Biomed Pharmacother; 2007 Aug; 61(7):400-7. PubMed ID: 17643927
    [Abstract] [Full Text] [Related]

  • 7. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
    Danesh FR, Kanwar YS.
    FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
    [Abstract] [Full Text] [Related]

  • 8. [The non-lipid effects of statins].
    Paragh G, Márk L, Katona E.
    Orv Hetil; 2004 Sep 12; 145(37):1903-10. PubMed ID: 15493621
    [Abstract] [Full Text] [Related]

  • 9. Potential vascular benefits of statins.
    Kinlay S.
    Am J Med; 2005 Dec 12; 118 Suppl 12A():62-7. PubMed ID: 16356810
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Beneficial cardiovascular pleiotropic effects of statins.
    Davignon J.
    Circulation; 2004 Jun 15; 109(23 Suppl 1):III39-43. PubMed ID: 15198965
    [Abstract] [Full Text] [Related]

  • 12. [The role of HMG-CoA reductase inhibitors in regulation of the inflammatory processes].
    Cecha J, Drabek G, Błazelonis A, Romanowski W, Zubelewicz-Szkodzińska B.
    Wiad Lek; 2004 Jun 15; 57(5-6):255-8. PubMed ID: 15518071
    [Abstract] [Full Text] [Related]

  • 13. Statins and the endothelium.
    Ii M, Losordo DW.
    Vascul Pharmacol; 2007 Jan 15; 46(1):1-9. PubMed ID: 16920035
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Statins: a treatment option for chronic heart failure?
    von Haehling S, Okonko DO, Anker SD.
    Heart Fail Monit; 2004 Jan 15; 4(3):90-7. PubMed ID: 15772704
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?
    März W, Köenig W.
    J Cardiovasc Risk; 2003 Jun 15; 10(3):169-79. PubMed ID: 12775949
    [Abstract] [Full Text] [Related]

  • 18. Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress.
    Mason RP, Walter MF, Jacob RF.
    Circulation; 2004 Jun 01; 109(21 Suppl 1):II34-41. PubMed ID: 15173061
    [Abstract] [Full Text] [Related]

  • 19. Statins and stroke.
    Endres M.
    J Cereb Blood Flow Metab; 2005 Sep 01; 25(9):1093-110. PubMed ID: 15815580
    [Abstract] [Full Text] [Related]

  • 20. [Is LDL reduction the only effect of statins? Pleiotropic effects of statins].
    Thiery J, Brügel M.
    Pharm Unserer Zeit; 2003 Sep 01; 32(6):472-8. PubMed ID: 14639828
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.